375 related articles for article (PubMed ID: 15944824)
1. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
[TBL] [Abstract][Full Text] [Related]
2. Effects of dexamethasone on the expression of transforming growth factor-beta in the mouse model of allergic rhinitis.
Lee SS; Won TB; Kim JW; Rhee CS; Lee CH; Hong SC; Min YG
Laryngoscope; 2007 Aug; 117(8):1323-8. PubMed ID: 17762268
[TBL] [Abstract][Full Text] [Related]
3. The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis.
Shin JH; Park HR; Kim SW; Park CS; Cho JH; Park YJ; Kim SW
Am J Rhinol Allergy; 2012; 26(2):e71-5. PubMed ID: 22487280
[TBL] [Abstract][Full Text] [Related]
4. Histological study on mast cells in conjunctiva of NC/Nga mice.
Inada N; Shoji J; Tabuchi K; Saito K; Sawa M
Jpn J Ophthalmol; 2004; 48(3):189-94. PubMed ID: 15175908
[TBL] [Abstract][Full Text] [Related]
5. Heparin treatment for allergic conjunctivitis in the experimental BALB/c model.
Kocatürk T; Kocatürk O; Kaplan A; Meteoğlu I; Cakmak H; Dayanir V
Ophthalmic Res; 2013; 50(1):65-71. PubMed ID: 23774193
[TBL] [Abstract][Full Text] [Related]
6. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
Hingorani M; Calder VL; Buckley RJ; Lightman S
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
[TBL] [Abstract][Full Text] [Related]
7. Topical Application of Interleukin-28A Attenuates Allergic Conjunctivitis in an Ovalbumin-Induced Mouse Model.
Chen J; Zhang J; Zhao R; Jin J; Yu Y; Li W; Wang W; Zhou H; Su SB
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):604-10. PubMed ID: 26886894
[TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus for the management of acute allergic conjunctivitis in a mouse model.
Barequet IS; Platner E; Sade K; Etkin S; Ziv H; Rosner M; Habot-Wilner Z
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1717-21. PubMed ID: 23553288
[TBL] [Abstract][Full Text] [Related]
9. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis.
Bhol KC; Schechter PJ
Br J Dermatol; 2005 Jun; 152(6):1235-42. PubMed ID: 15948987
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis.
Gimenes AD; Andrade TR; Mello CB; Ramos L; Gil CD; Oliani SM
Exp Eye Res; 2015 May; 134():24-32. PubMed ID: 25795053
[TBL] [Abstract][Full Text] [Related]
11. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
Stern ME; Siemasko K; Gao J; Duong A; Beauregard C; Calder V; Niederkorn JY
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
[TBL] [Abstract][Full Text] [Related]
12. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.
Fukuda K; Ohbayashi M; Morohoshi K; Zhang L; Liu FT; Ono SJ
J Allergy Clin Immunol; 2009 Oct; 124(4):827-33.e2. PubMed ID: 19660804
[TBL] [Abstract][Full Text] [Related]
13. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
14. Topical cyclosporine inhibits mast cell-mediated conjunctivitis.
Whitcup SM; Chan CC; Luyo DA; Bo P; Li Q
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2686-93. PubMed ID: 8977483
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-17F in a mouse model of allergic asthma.
Suzuki S; Kokubu F; Kawaguchi M; Homma T; Odaka M; Watanabe S; Ieki K; Matsukura S; Kurokawa M; Takeuchi H; Sasaki Y; Huang SK; Adachi M; Ota H
Int Arch Allergy Immunol; 2007; 143 Suppl 1():89-94. PubMed ID: 17541285
[TBL] [Abstract][Full Text] [Related]
16. Topical Administration of β-1,3-Glucan to Modulate Allergic Conjunctivitis in a Murine Model.
Lee HS; Kwon JY; Joo CK
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1352-60. PubMed ID: 27002295
[TBL] [Abstract][Full Text] [Related]
17. A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis.
Lehto M; Savinko T; Wolff H; Kvist PH; Kemp K; Lauerma A; Alenius H
Int Immunopharmacol; 2010 Apr; 10(4):377-84. PubMed ID: 20074670
[TBL] [Abstract][Full Text] [Related]
18. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
[TBL] [Abstract][Full Text] [Related]
19. The attenuative effect of purified protein derivative sensitization on T helper 2 reaction and eosinophil infiltration of the lung in ovalbumin sensitized mice.
Cui X; Guo Z; Xu W; Chen Y; Zhu Y
Chin Med J (Engl); 1998 Oct; 111(10):940-4. PubMed ID: 11189245
[TBL] [Abstract][Full Text] [Related]
20. Role of VLA-4 in the development of allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
